Keywords: لیراگلوتید; GLP-1 agonist; Liraglutide; Insulin resistance; Cognitive function, fMRI; Hippocampus;
مقالات ISI لیراگلوتید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لیراگلوتید; Cerebral ischemia; liraglutide; glucagon-like peptide 1 (GLP-1); angiogenesis; vascular endothelial growth factor (VEGF);
Keywords: لیراگلوتید; Adherence; Anti-obesity medications; Long-term; Persistence; Real-world; Retrospective; Obesity; Liraglutide; AOM; Pharmacotherapy;
Keywords: لیراگلوتید; Glucagon-like peptide-1; liraglutide; neprilysin inhibition; sacubitril/valsartan;
Keywords: لیراگلوتید; NAFLD; NASH; Obeticholic acid; Elafibranor; Liraglutide; Cenicriviroc; Selonsertib;
Keywords: لیراگلوتید; ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
Keywords: لیراگلوتید; Type 2 diabetes; Liraglutide; Real-life study; Biomarker; Insulin tolerance test;
Keywords: لیراگلوتید; Quality by Design; Pharmaceutical Risk Assessment; Peptide formulation; Oral peptide delivery; GLP 1 analog; Liraglutide; Polymeric nanoparticles;
Keywords: لیراگلوتید; Major depressive disorder; Bipolar disorder; Glucagon-like peptide-1; GLP-1R agonists; Liraglutide; Obesity; Insulin resistance; Weight loss;
Keywords: لیراگلوتید; Diabetes; Liraglutide; Oral drug delivery; Sodium alginate; Chitosan; Nanocapsules;
Keywords: لیراگلوتید; Estimated glomerular filtration rate; Kidney function; Liraglutide; Obesity; Serum creatinine;
Keywords: لیراگلوتید; Colombia; cost-effectiveness analysis; diabetes; dulaglutide; insulin glargine; liraglutide; quality-adjusted life-years;
Keywords: لیراگلوتید; Cardiac ultrasonography; Cardiac function; Glucagon-like peptide 1 analog; Liraglutide; Type 2 diabetes mellitus;
Keywords: لیراگلوتید; Androgens; Anti-Müllerian hormone; Liraglutide; Menstruation; Ovarian morphology; Polycystic ovary syndrome;
Keywords: لیراگلوتید; effectiveness; liraglutide; real world; type 2 diabetes;
Keywords: لیراگلوتید; AD; Alzheimer's disease; APP/PS1; amyloid precursor protein/presenilin 1; Aβ; β-amyloid; CNS; central nervous system; CTRL; control; EPM; elevated plus maze; FST; forced swimming test; GLP-1R; glucagon-like peptide-1 receptor; i.c.v.; intracerebrovent
Keywords: لیراگلوتید; Non-alcoholic fatty liver disease (NAFLD); Non-alcoholic steatohepatitis (NASH); Sleeve gastrectomy; Liraglutide; Obeticholic acid;
Keywords: لیراگلوتید; Anxiety; Cognition; Depression; GLP-1; Liraglutide; Sitagliptin
Keywords: لیراگلوتید; GLP-1 receptor agonist; Liraglutide; Diastolic dysfunction; Type 2 diabetes; Diabetic cardiomyopathy; Diabetic heart disease;
Keywords: لیراگلوتید; diabetes mellitus; exenatide; glycemic control; liraglutide; observational study; weight;
Keywords: لیراگلوتید; Obesity; Weight management; Pharmacotherapy; Orlistat; Phentermine/topiramate ER; Lorcaserin; Naltrexone SR/bupropion SR; Liraglutide;
Keywords: لیراگلوتید; Bariatric surgery; Liraglutide; Type 2 diabetes; GLP-1 receptor agonists;
Keywords: لیراگلوتید; Liraglutide; Type 2 Diabetes; India
Keywords: لیراگلوتید; Binge eating; Obesity; Glucagon-like peptide-1; Liraglutide; Ghrelin
Keywords: لیراگلوتید; Type 2 diabetes mellitus; Cardiovascular disease; Glucagon-like peptide-1; GLP-1; Liraglutide; Biguanides
Keywords: لیراگلوتید; GLP-1; liraglutide; type 2 diabetes; creatinine; glomerular filtration rate;
Keywords: لیراگلوتید; Bariatric surgery; counterweight; liraglutide; orlistat; Total Diet Replacement
Keywords: لیراگلوتید; antiobesity drugs; liraglutide; modest weight loss; obesity; prediabetes; type 2 diabetesmédicaments antiobésité; liraglutide; perte de poids modeste; obésité; prédiabète; diabète de type 2
Keywords: لیراگلوتید; Aortic rings; Central (aortic) vasodilatation; GLP-1; Liraglutide;
Keywords: لیراگلوتید; GLP-1; glycemic control; liraglutide; type 2 diabetes; weight loss;
Keywords: لیراگلوتید; albiglutide; dulaglutide; exenatide; GLP-1 receptor agonists; liraglutide; lixisenatide;
Keywords: لیراگلوتید; Canada; cost; cost-effectiveness; diabetes mellitus; liraglutide; Quebec;
Keywords: لیراگلوتید; GLP-1; Liraglutide; Metformin; Gastrointestinal side effects;
Keywords: لیراگلوتید; Type 2 diabetes; Liraglutide; Adipocytokines; GLP-1 analogs; Visfatin;
Keywords: لیراگلوتید; Glucagon-like peptide 1; Alzheimer's disease; Parkinson's disease; Liraglutide; Neuroimaging; FDG-PET; MRI; Neuroinflammation; Amyloid imaging;
Keywords: لیراگلوتید; Exenatide; Exenatide once-weekly; GLP-1 receptor agonists; Liraglutide; Lixisenatide; Type 2 diabetes
Keywords: لیراگلوتید; Alzheimer's disease; Glucagon-like peptide-1; Inflammation; Insulin receptor; Insulin receptor substrate-1; Insulin signaling; Hippocampus; Liraglutide; Streptozotocin; Type 3 diabetes;
Keywords: لیراگلوتید; liraglutide; type 2 diabetes mellitus; protein binding; plasma proteins; human serum albumin; in vitro method; equilibrium dialysis; insulin detemir; acylated peptides;
Keywords: لیراگلوتید; Neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; Infection; Incretins; GLP-1; Liraglutide;
Keywords: لیراگلوتید; ER; endoplasmic reticulum; UPR; unfolded protein response; PERK; double-stranded RNA-activated protein kinase (PKR)-like ER kinase; ATF-6; activating transcription factor 6; IRE1; inositol requiring enzyme 1; Bip; luminal binding protein (also known as GR
Keywords: لیراگلوتید; Liraglutide; GLP-1 receptor; POMC; Orexin; 5-HT; Food intake
Keywords: لیراگلوتید; energy homeostasis; liraglutide; lorcaserin; obesity; orlistat; weight losshoméostasie énergétique; liraglutide; lorcasérine; obésité; orlistat; perte de poids
Keywords: لیراگلوتید; Diabetes type 2; GLP-1; Liraglutide; Overweight; Insulin injections
Keywords: لیراگلوتید; Liraglutide; LC-MS/MS; Rat plasma; Selective; Pharmacokinetics;
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patients
Keywords: لیراگلوتید; Type 2 diabetes; Treatment; GLP-1 receptor agonists; Exenatide; Liraglutide;
Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic
Keywords: لیراگلوتید; Xultophy; Glucagon-like peptide 1 analogues; Liraglutide; Insulin; Degludec;
Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells
Keywords: لیراگلوتید; Liraglutide; NLRP3 inflammasome; Pyroptosis; SIRT1; H9c2 cells;
Liraglutide Protects Neurite Outgrowth of Cortical Neurons Under Oxidative Stress though Activating the Wnt Pathway
Keywords: لیراگلوتید; Cerebral ischemia; liraglutide; cortical neuron; neurite outgrowth; the Wnt pathway.;
Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet
Keywords: لیراگلوتید; Liraglutide; Non-alcoholic fatty liver disease; NLRP3 inflammasome;
Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus
Keywords: لیراگلوتید; Liraglutide; GLP-1; Apoptosis; Inflammation; Neuroprotection; Insulin;